Viewing Study NCT00263666


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-01-04 @ 7:47 AM
Study NCT ID: NCT00263666
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2005-12-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-03-16
Start Date Type: ACTUAL
Primary Completion Date: 2008-02-07
Primary Completion Date Type: ACTUAL
Completion Date: 2008-02-13
Completion Date Type: ACTUAL
First Submit Date: 2005-12-08
First Submit QC Date: None
Study First Post Date: 2005-12-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-02-13
Results First Submit QC Date: None
Results First Post Date: 2009-03-13
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-04
Last Update Post Date: 2020-11-23
Last Update Post Date Type: ACTUAL